U.S. Markets open in 5 hrs 34 mins
  • S&P Futures

    3,968.50
    +6.50 (+0.16%)
     
  • Dow Futures

    33,893.00
    +36.00 (+0.11%)
     
  • Nasdaq Futures

    11,558.00
    +33.25 (+0.29%)
     
  • Russell 2000 Futures

    1,840.80
    +3.00 (+0.16%)
     
  • Crude Oil

    78.68
    +0.48 (+0.61%)
     
  • Gold

    1,771.70
    +8.00 (+0.45%)
     
  • Silver

    21.55
    +0.11 (+0.51%)
     
  • EUR/USD

    1.0368
    +0.0033 (+0.3214%)
     
  • 10-Yr Bond

    3.7480
    0.0000 (0.00%)
     
  • Vix

    21.82
    -0.39 (-1.76%)
     
  • GBP/USD

    1.1983
    +0.0033 (+0.2732%)
     
  • USD/JPY

    138.6890
    +0.0550 (+0.0397%)
     
  • BTC-USD

    16,900.13
    +385.40 (+2.33%)
     
  • CMC Crypto 200

    401.17
    +12.45 (+3.20%)
     
  • FTSE 100

    7,525.37
    +13.37 (+0.18%)
     
  • Nikkei 225

    27,968.99
    -58.85 (-0.21%)
     

AdaptHealth Shares Fall As Q2 Profits Come Below Expectation, Reaffirms Annual Guidance

  • AdaptHealth Corp (NASDAQ: AHCOdelivered Q2 revenue of $727.6 million, +17.9% Y/Y, beating the consensus of $724.22 million.

  • Adjusted EBITDA reached $150 million, +1.8% Y/Y.

  • The company said that Q2 revenue and Adjusted EBITDA are consistent with internal expectations as it continues to overcome challenges resulting from industry shortages of CPAP equipment.

  • On a sequential basis, the adjusted EBITDA margin increased 110 basis points to 20.6%, as the company continues to manage through the inflationary environment and supply chain challenges.

  • The company reported EPS of $0.09, down from $0.12 a year ago and the consensus of $0.26.

  • Cash flow from operations was $103.5 million.

  • AdaptHealth says sleep categories showed strong sequential growth as the supply of PAP machines continues to improve relative to recent quarters.

  • Guidance: AdaptHealth reaffirms FY22 sales of $2.84 - $3.04 billion versus the consensus of $2.96 billion.

  • It forecasts adjusted EBITDA of $615-$675 million.

  • Price Action: AHCO shares are down 14.50% at $22 during the market session on the last check Tuesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.